Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychiatry and sleep medicine

Sectors
Healthcare
Life Sciences
First Invested
2007
Early
Company Status
IPO/Acquired
NASDAQ: PRTK
Acquired by Novo Holdings and Gurnet Point Capital